ProFunds Pharmaceuticals UltraSector Inv PHPIX
- NAV / 1-Day Return 25.64 / +2.07 %
- Total Assets 2.9 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.780%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Trading—Leveraged Equity
- Investment Style Mid Blend
- Min. Initial Investment 15,000
- Status Open
- TTM Yield 0.52%
- Turnover 272%
USD | NAV as of Jul 27, 2024 | 1-Day Return as of Jul 27, 2024, 12:12 AM GMT+0
Morningstar’s Analysis PHPIX
There is no Morningstar’s Analysis data available.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 36.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Soc 5.18% , 5/1/2024 | 7.68 | 212,000 | Cash and Equivalents |
Ntm 5.18% , 5/1/2024 | 6.41 | 177,000 | Cash and Equivalents |
Cra 5.19% , 5/1/2024 | 6.08 | 168,000 | Cash and Equivalents |
Intra-Cellular Therapies Inc | 3.84 | 106,063 | Healthcare |
Perrigo Co PLC | 3.84 | 105,949 | Healthcare |
Merck & Co Inc | 3.78 | 104,281 | Healthcare |
Eli Lilly and Co | 3.71 | 102,324 | Healthcare |
Organon & Co Ordinary Shares | 3.64 | 100,550 | Healthcare |
Axsome Therapeutics Inc | 3.60 | 99,428 | Healthcare |
Catalent Inc | 3.57 | 98,519 | Healthcare |